Stocks
Health Care
dvax
Dynavax Technologies
NASDAQ: DVAX
+4.25 (+38.19%)
15.38
USD
At close at Dec 25, 19:35 UTC
Income Statement
Revenue
277.25M
Gross Profit
227.80M
Operating Income
-4.12M
Pretax Income
-40.61M
Net Income
27.31M
EBITDA
45.70M
EBIT
37.65M
Earnings Per Share
0.21
Balance Sheet
Cash & Cash Equivalents
114.94M
Total Debt
250.67M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
634.89M
Book Value Per Share
4.85
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.